Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

How to Maximize Cannabis Yield: 5 Croptober Myths & Proven Tactics

Every Croptober, growers waste time on folklore instead of physics. We break down the science…

6 hours ago

Cannabis voter guide to the 2026 midterm elections

Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…

2 days ago

Harvest road trip 2026: Emerald Triangle genetics to watch

Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…

3 days ago

The DEA Approved an Ayahuasca Church—Can You Start a Cannabis Religion?

This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…

3 days ago

The 5 Celebrities Who Could Force Washington to Legalize Cannabis Overnight

The cannabis industry does not need another study, another tax revenue report, or another state-level…

5 days ago

What If We Regulated Alcohol Like Cannabis? The Hypocrisy of Legal Weed Laws

A liquor-retail trade group argued that the state’s cannabis oversight is lax and should look…

5 days ago